Asthma with Positive Bronchodilator Response
This patient has asthma, confirmed by the significant bronchodilator response of 12% and 200 mL increase in FEV1, and should be initiated on inhaled corticosteroid (ICS)-containing controller therapy immediately.
Diagnostic Interpretation
Your spirometry results definitively indicate asthma based on the following:
- FEV1/FVC ratio of 78% is normal (obstruction is defined as <70% in adults or <85% in children ages 5-18) 1, 2
- The positive bronchodilator response meets both criteria: ≥12% AND ≥200 mL increase in FEV1, which is the established threshold for significant reversibility in adults 1
- The mildly reduced FVC that normalizes post-bronchodilator is characteristic of asthma, where airway obstruction can initially reduce FVC but improves with bronchodilation 3
This pattern—normal FEV1/FVC ratio with reduced FVC that responds to bronchodilator—is commonly seen in asthma patients and should not be misinterpreted as restrictive disease 3. The key diagnostic feature here is the reversible airflow limitation, which is the hallmark of asthma 1.
Treatment Recommendation
All adults and adolescents with asthma must receive ICS-containing medication and should never be treated with short-acting beta-agonist (SABA) alone 4. The 2024 GINA guidelines provide two treatment tracks:
Preferred Approach (Track 1):
- As-needed low-dose ICS-formoterol combination as both controller and reliever therapy
- This eliminates SABA-only treatment, which is associated with increased morbidity and mortality 4
Alternative Approach (Track 2):
- Daily ICS controller therapy PLUS separate SABA as reliever
- Less preferred due to adherence challenges with separate inhalers
Critical Management Elements
Provide a written asthma action plan at the initial visit—this is non-negotiable for reducing exacerbations and hospitalizations 4.
Monitor the following parameters over time 5:
- Pre- and post-bronchodilator FEV1 percent predicted
- Number of exacerbations requiring oral corticosteroids per year
- Symptom control and quality of life measures
Important Caveats
Do not be misled by the normal FEV1/FVC ratio—bronchodilator responsiveness is the key diagnostic criterion here 1. The spirometric response to bronchodilator has limitations: it shows poor correlation with other measures of airway hyperresponsiveness 6 and can have a "ceiling effect" when baseline values are near normal 1. However, meeting both the 12% and 200 mL criteria provides objective confirmation of asthma diagnosis 1.
Avoid using SABA monotherapy, as this approach is outdated and associated with worse outcomes including increased mortality risk 4. Even patients with mild or well-controlled asthma (where baseline FEV1 may be normal) require ICS-containing therapy 1.
The mildly reduced FVC should normalize with appropriate ICS therapy and does not require additional restrictive disease workup given the clear bronchodilator response 2, 3.